Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE
President, Medical Director, Principal Investigator                 View CV

Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. He is a nationally and internationally recognized authority on Diabetes and its comprehensive approach to management, obesity, Dyslipidemia, HTN, insulin resistance, pre-diabetes, and the prevention of cardiovascular disease. He is a leader in understanding the body’s metabolic and energy systems and the kidney's role in Glucose homeostasis.

A Master of the American College of Endocrinology, Fellow of the American Society of Preventive Cardiology, American College of Physicians, and The National Lipid Association He is chair of the AACE task force of the 2019 Lipid management Algorithm to Prevent cardiovascular disease, Member AACE/ACE 2020 Task Force to Update the Comprehensive Diabetes Management Algorithm and of the 2020 AACE/ACE Combined Guidelines for CGM & Pumps. A member of the AACE Lipid & CV Health, Diabetes & Obesity Disease networks. Past president of the American College of Endocrinology (ACE) & of the American Association of Clinical Endocrinologists (AACE) and the Pacific Lipid Association; and a past member, Board of Directors, American Association for Preventive Cardiology. He is chair Founder & program director of the acclaimed annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease and the Heart in Diabetes- initiative and Medical Congress; Chair & Founder of the International Lipid Forum, an Associate Editor of the Journal of Diabetes, member of the editorial board of several journals and a frequent guest editor for publications such as the Journal of Clinical Hypertension.

Chair Task Force & Writing committee Co-Chair- AACE 2017 Lipid Guideline; Chair the AACE 2011 & 2015 Comprehensive Diabetes Guidelines; member of the AACE 2013-20 Comprehensive Diabetes Algorithms. He Chaired the consensuses on SGLT2i & DKA, Diabetes, Obesity & Cancer, Insulin Resistance Syndrome, lipodystrophy Clinical Approach and Pre-Diabetes- Clinical impact. Handelsman has been listed repeatedly in “Top Doctors of Los Angeles,” “Southern California Super Doctors,” “The Leading Physicians of the world,” “America’s Best Physicians” and “Best Doctors of America.” He published over 130 Peer reviewed original research & review papers, position and consensus statements, editorials, clinical practice guidelines, and book chapters. His Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity”, published by Professional Communications, Inc.

Nava Mekel
Executive Director, Medical Education Management Division

Nava has extensive administrative experience and has been in the Medical Meeting Management field for over 20 years. Her experience, along with her leadership skills and genuine love of people, makes her uniquely qualified to direct the Medical Education Division of the Metabolic Institute of America.


Following wide experience in medical education programs, Nava has been the course director of the Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) since its inception in 2003. And the annual heart in Diabetes congress since 2017. She leads both local and nationwide educational projects, medical conferences, and CME meetings, and has substantial experience and expertise in developing and applying for corporate grant sponsorship and CME programs. She also provides administrative services including attendee registration, events, travel planning, and general event coordination.


Nava has experience in the management of nonprofit associations. She served as the secretary of a non-profit association organizing large festivals in Los Angeles and currently has been serving as the administrator of the Metabolic Endocrine Education Foundation.

Originally from Israel, Nava has called California home since 1992. She earned a Computer Graphic Design degree from California State University Northridge.

She is married and lives with her husband and two daughters in a lovely southern California community.


Contact Nava at

Mike Heinzel
Senior Clinical Trials Coordinator

N.C.M.A., N.C.P.T., EMT-B,

Mike has been a research study coordinator and lab technician for over 21 years.

He has been leading studies in metabolic diseases and endocrinology, which include research in diabetes, lipid disorders, and high blood pressure. He acquired skills and was involved in research in immunology, infectious diseases, and HIV, as well as various hormonal conditions including vitamin D and parathyroid hormone disorder.

Mike is experienced and proficient in conducting studies from Phase II through phase IV.

Mike’s other skills include BLS Instructor, EMT,  I.A.T.A. Certified, Medic with Ventura County Medical Reserve Corp., and Remote CRA for Clinical Cancer Trials.

The following is a list of several recent studies:

  • Improving lipid profile in patients with dyslipidemia (2002)

  • Point-of-care vs. laboratory testing – Study for adherence on glycemia (2002)

  • Observational study on the effect of active vitamin D in the treatment of hyperparathyroidism (2003)

  • A potential new diabetes compound in Metformin-treated Subjects with T2DM (2006)

  • Comparison of long-acting insulin vs. oral in triple-agent therapy (2007)

  • A study of a potential new diabetes compound for the treatment of T2DM in treatment-naïve subjects (2007)

  • Treatment or prevention of diabetes with a cholesterol-lowering, non-absorbable drug which is also indicated for diabetes (2008)

  • Treatment of diabetes with a potentially new weight loss compound (2008)

Contact Mike at

Adrienne Stevens, EdD

Director of Scientific and Medical Communication


Experienced working in medical strategy and scientific communications for much of her professional career, Dr. Stevens is skilled in identifying key medical content and translating data to a variety of audiences. She has led field medical affairs teams in the dissemination and education in such areas as cardiometabolic risk reduction, lipidology, obesity, diabetes, and cardiology (Amarin Pharma, Eisai Inc.),  and in publications (Cardinal Health). Involved in the integration and development of medical education competencies, Adrienne has held leadership positions (Medscape, VBWG) and in medical advertising companies. She is the Managing Director for the International Lipid Forum website, identifying digital content pertinent to lipid management for medical professionals.


Dr. Stevens earned her advanced Master's and Doctorate Degrees from Columbia University’s Teachers College while focusing on research as an Officer of Research, College of Physicians & Surgeons, Columbia University, in autonomic physiology/cardiovascular-focused studies. She served on the Writing Committee for Masters students, Institute of Human Nutrition, Columbia University, and is a reviewer for several diabetes journals. A graduate of the Juilliard School, Adrienne supports the performing arts via worldwide educational initiatives in exercise physiology and nutrition awareness for dancers and athletes (

Contact Adrienne at